Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Conditions
Charcot Marie Tooth Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Richard A Lewis, MD)Stanford University, Palo Alto, California, United States
Contact: Principal Investigator (John Day, MD, PhD)University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Vera Fridman, MD)University of Connecticut/Connecticut Children's Medical Center, Hartford, Connecticut, United States
Contact: Study coordinator (Jennifer Twatchtman-Bassett, M.S.) · jtwachtman@connecticutchildrens.org · 860.837.6512Contact: Principal Investigator (Gyula Acsadi, MD, PhD)Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Diana Bharucha-Goebel, MD)University of Miami, Miami, Florida, United States
Contact: Principal Investigator (Stephan Zuchner, MD)Contact: Principal Investigator (Mario Saporta, MD)Nemours Children's Health, Orlando, Florida, United States
Contact: Principal Investigator (Omer Abdul Hamid, MD)Nemours Children's Hospital, Orlando, Florida, United States
Contact: Principal Investigator (Omer Abdul Hamid, MD)University of Iowa, Iowa City, Iowa, United States
Contact: Principal Investigator (Michael E Shy, MD)Johns Hopkins University, Baltimore, Maryland, United States
Contact: Principal Investigator (Bipasha Mukherjee-Clavin, MD)Harvard/Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Reza Seyedsadjadi, MD)University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Brett McCray, MD, PhD)University of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (David Walk, MD)University of Rochester, Rochester, New York, United States
Contact: Principal Investigator (David Herrmann, MD)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Sabrina Yum, MD)University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Steven Scherer, MD)St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Richard Finkel, MD)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Principal Investigator (Seth Perlman, MD)University of Westmead, Sydney, New South Wales, Australia
Contact: Study coordinator (Gabrielle Donlevy) · gabrielle.donlevy@health.nsw.gov.au · +61 2 9845 1904Contact: Principal Investigator (Joshua Burns, PhD)The Hospital for Sick Children, Toronto, Ontario, Canada
Contact: Principal Investigator (Hernan Gonorazky, MD)C. Besta Neurological Institute, Milan, Milan, Italy
Contact: Study coordinator (Daniela Calabrese) · daniela.calabrese@istituto-besta.it · +39-02 2394 3001Contact: Principal Investigator (Davide Pareyson, MD)National Hospital of Neurology and Neurosurgery, London, England, United Kingdom
Contact: Principal Investigator (Mary Reilly, MD)
Study leads
Michael E Shy, MD
Principal Investigator
University of Iowa